Corpus GrippeCanadaV3 - Exploration (Accueil)

Index « Mesh.i » - entrée « Cost-Benefit Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cost of Illness < Cost-Benefit Analysis < Costs and Cost Analysis  Facettes :

List of bibliographic references indexed by Cost-Benefit Analysis

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]
Ident.Authors (with country if any)Title
000027 (2019) Andrew J. Leidner [États-Unis] ; Neil Murthy [États-Unis] ; Harrell W. Chesson [États-Unis] ; Matthew Biggerstaff [États-Unis] ; Charles Stoecker [États-Unis] ; Aaron M. Harris [États-Unis] ; Anna Acosta [États-Unis] ; Kathleen Dooling [États-Unis] ; Carolyn B. Bridges [États-Unis]Cost-effectiveness of adult vaccinations: A systematic review.
000079 (2017) Eon E K. Ting [Canada] ; Beate Sander [Canada] ; Wendy J. Ungar [Canada]Systematic review of the cost-effectiveness of influenza immunization programs.
000085 (2017) Edward W. Thommes [Canada] ; Morgan Kruse [États-Unis] ; Michele Kohli [Canada] ; Rohita Sharma [Canada] ; Stephen G. Noorduyn [Canada]Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
000149 (2016) Debbie L. Becker [Canada] ; Ayman Chit [États-Unis, Canada] ; Carlos A. Diazgranados [États-Unis] ; Michael Maschio [Canada] ; Eddy Yau [Canada] ; Michael Drummond [Royaume-Uni]High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors.
000152 (2016) Corwin A. Robertson [États-Unis] ; Carlos A. Diazgranados [États-Unis] ; Michael D. Decker [États-Unis] ; Ayman Chit [États-Unis, Canada] ; Monica Mercer [États-Unis] ; David P. Greenberg [États-Unis]Fluzone® High-Dose Influenza Vaccine.
000164 (2016) Léon Nshimyumukiza [Canada] ; Xavier Douville [Canada] ; Diane Fournier [Canada] ; Julie Duplantie [Canada] ; Rana K. Daher [Canada] ; Isabelle Charlebois [Canada] ; Jean Longtin [Canada] ; Jesse Papenburg [Canada] ; Maryse Guay [Canada] ; Maurice Boissinot [Canada] ; Michel G. Bergeron [Canada] ; Denis Boudreau [Canada] ; Christian Gagné [Canada] ; François Rousseau [Canada] ; Daniel Reinharz [Canada]Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment.
000207 (2015) P G Van Buynder [Canada] ; S. Konrad [Canada] ; F. Kersteins [Canada] ; E. Preston [Canada] ; P D Brown [Canada] ; D. Keen [Canada] ; N J Murray [Canada]Healthcare worker influenza immunization vaccinate or mask policy: strategies for cost effective implementation and subsequent reductions in staff absenteeism due to illness.
000223 (2015) Edward W. Thommes [Canada] ; Afisi Ismaila [Canada] ; Ayman Chit [Canada] ; Genevieve Meier [Belgique] ; Christopher T. Bauch [Canada]Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
000234 (2015) Ayman Chit [Canada] ; Julie Roiz [Royaume-Uni] ; Samuel Aballea [France]An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model.
000238 (2015) Alison K. Thompson [Canada] ; Maxwell J. Smith ; Christopher W. Mcdougall ; Cécile Bensimon ; Daniel Felipe Perez"With human health it's a global thing": Canadian perspectives on ethics in the global governance of an influenza pandemic.
000296 (2014) Meghann Gregg [Oman] ; Gordon Blackhouse [Canada] ; Mark Loeb [Canada] ; Ron Goeree [Canada]Economic evaluation of an influenza immunization strategy of healthy children.
000451 (2012) Stephanie R. Earnshaw [États-Unis] ; Cheryl L. Mcdade ; Giovanni Zanotti ; Raymond A. Farkouh ; David StruttonCost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.
000473 (2011) Bohdan Nosyk [Canada] ; Behnam Sharif ; Huiying Sun ; Curtis Cooper ; Aslam H. AnisThe cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.
000525 (2011) David N. Fisman [Canada] ; Ashleigh R. TuiteEstimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada.
000538 (2011) Elizabeth Rolland-Harris ; Martin TepperCost-effectiveness of Ontario's pandemic vaccine program.
000559 (2011) Jennifer A. Pereira [Canada] ; Julie Foisy ; Jeffrey C. Kwong ; Christine L. Heidebrecht ; Susan Quach ; Sherman D. Quan ; Maryse Guay ; Beate SanderA cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns.
000609 (2010) Beate Sander [Canada] ; Chris T. Bauch ; David Fisman ; Robert A. Fowler ; Jeffrey C. Kwong ; Andreas Maetzel ; Allison Mcgeer ; Janet Raboud ; Damon C. Scales ; Marija Zivkovic Gojovic ; Murray KrahnIs a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
000631 (2010) Beate Sander [Canada] ; Jeffrey C. Kwong ; Chris T. Bauch ; Andreas Maetzel ; Allison Mcgeer ; Janet M. Raboud ; Murray KrahnEconomic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis.
000847 (2006) Danuta M. Skowronski [Canada] ; John C. Woolcott ; S Aleina Tweed ; Robert C. Brunham ; Fawziah MarraPotential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.
000892 (2005) Nancy A. Risebrough [Canada] ; Susan K. Bowles ; Andrew E. Simor ; Alison Mcgeer ; Paul I. OhEconomic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.
000920 (2004) A. Banerji ; I. Tyler ; M S Finkelstein ; E. Gournis ; M F Pritchard ; F. Kolbe ; R. ShahinEffectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003-2004.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Cost-Benefit Analysis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Cost-Benefit Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Cost-Benefit Analysis
}}

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020